Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Intravitreal triamcinolone for the treatment of idiopathic juxtafoveal telangiectasis.

Authors: Emily Y Chew; Traci E Clemons; Tunde Peto; Ferenc B Sallo; Avner Ingerman; Weng Tao; Lawrence Singerman; Steven D Schwartz; Neal S Peachey; Alan C Bird
Journal: Am J Ophthalmol Date: 2014-12-19 Impact factor: 5.258

5. Intraocular pressure alterations following intravitreal triamcinolone acetonide.

Authors: D J Rhee; R E Peck; J Belmont; A Martidis; M Liu; J Chang; J Fontanarosa; M R Moster
Journal: Br J Ophthalmol Date: 2006-04-05 Impact factor: 4.638

6. Bevacizumab in the treatment of idiopathic macular telangiectasia.

Authors: Maria-Andreea Gamulescu; Andreas Walter; Helmut Sachs; Horst Helbig
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2008-04-02 Impact factor: 3.117

7. Idiopathic juxtafoveolar retinal telangiectasis: a current review.

Authors: Sawsan R Nowilaty; Hanan N Al-Shamsi; Wajeeha Al-Khars
Journal: Middle East Afr J Ophthalmol Date: 2010-07

Review 8. Macular telangiectasia type 2.

Authors: Peter Charbel Issa; Mark C Gillies; Emily Y Chew; Alan C Bird; Tjebo F C Heeren; Tunde Peto; Frank G Holz; Hendrik P N Scholl
Journal: Prog Retin Eye Res Date: 2012-12-03 Impact factor: 21.198

Review 9. [Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases].

Authors: J B Jonas; I Kreissig; B Kamppeter; R F Degenring
Journal: Ophthalmologe Date: 2004-02 Impact factor: 1.059

10. Indocyanine-green-mediated photothrombosis (IMP) with intravitreal triamcinolone acetonide for macular edema secondary to group 2A idiopathic parafoveal telangiectasis without choroidal neovascularization: a pilot study.

Authors: J Fernando Arevalo; Juan G Sanchez; Reinaldo A Garcia; Lihteh Wu; Maria H Berrocal; Francisco J Rodriguez; Alvaro Rodríguez; Liliana Andrea Novoa; Rafael Garcia-Amaris
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2007-07-10 Impact factor: 3.117